-
Market growth of Nursing Care Research in the last and upcoming ten years
Susan E. Mazer
Editorial: Clinical Investigation
-
Market growth of Nursing Care Research in the last and upcoming ten years
Susan E. Mazer
Editorial: Clinical Investigation
-
Market growth of Nursing Care Research in the last and upcoming ten years
Susan E. Mazer
Editorial: Clinical Investigation
-
Market growth of Nursing Care Research in the last and upcoming ten years
Susan E. Mazer
Editorial: Clinical Investigation
-
Market growth of Nursing Care Research in the last and upcoming ten years
Susan E. Mazer
Editorial: Clinical Investigation
-
Market growth of Nursing Care Research in the last and upcoming ten years
Susan E. Mazer
Editorial: Clinical Investigation
-
Market growth of Nursing Care Research in the last and upcoming ten years
Susan E. Mazer
Editorial: Clinical Investigation
-
Market growth of Nursing Care Research in the last and upcoming ten years
Susan E. Mazer
Editorial: Clinical Investigation
-
STRATOS 1 and 2: considerations in clinical trial design for a fully human monoclonal antibody in severe asthma
Reynold A Panettieri Jr, Christopher Brightling, Ulf Sjobring, AnnaMaria Peterffy, Goran Tornling, Sami Z Daoud, Koustubh Ranade, Sally Hollis & Gene Colice
Protocol: Clinical Investigation
-
STRATOS 1 and 2: considerations in clinical trial design for a fully human monoclonal antibody in severe asthma
Reynold A Panettieri Jr, Christopher Brightling, Ulf Sjobring, AnnaMaria Peterffy, Goran Tornling, Sami Z Daoud, Koustubh Ranade, Sally Hollis & Gene Colice
Protocol: Clinical Investigation
-
STRATOS 1 and 2: considerations in clinical trial design for a fully human monoclonal antibody in severe asthma
Reynold A Panettieri Jr, Christopher Brightling, Ulf Sjobring, AnnaMaria Peterffy, Goran Tornling, Sami Z Daoud, Koustubh Ranade, Sally Hollis & Gene Colice
Protocol: Clinical Investigation
-
STRATOS 1 and 2: considerations in clinical trial design for a fully human monoclonal antibody in severe asthma
Reynold A Panettieri Jr, Christopher Brightling, Ulf Sjobring, AnnaMaria Peterffy, Goran Tornling, Sami Z Daoud, Koustubh Ranade, Sally Hollis & Gene Colice
Protocol: Clinical Investigation
-
STRATOS 1 and 2: considerations in clinical trial design for a fully human monoclonal antibody in severe asthma
Reynold A Panettieri Jr, Christopher Brightling, Ulf Sjobring, AnnaMaria Peterffy, Goran Tornling, Sami Z Daoud, Koustubh Ranade, Sally Hollis & Gene Colice
Protocol: Clinical Investigation
-
STRATOS 1 and 2: considerations in clinical trial design for a fully human monoclonal antibody in severe asthma
Reynold A Panettieri Jr, Christopher Brightling, Ulf Sjobring, AnnaMaria Peterffy, Goran Tornling, Sami Z Daoud, Koustubh Ranade, Sally Hollis & Gene Colice
Protocol: Clinical Investigation
-
STRATOS 1 and 2: considerations in clinical trial design for a fully human monoclonal antibody in severe asthma
Reynold A Panettieri Jr, Christopher Brightling, Ulf Sjobring, AnnaMaria Peterffy, Goran Tornling, Sami Z Daoud, Koustubh Ranade, Sally Hollis & Gene Colice
Protocol: Clinical Investigation
-
STRATOS 1 and 2: considerations in clinical trial design for a fully human monoclonal antibody in severe asthma
Reynold A Panettieri Jr, Christopher Brightling, Ulf Sjobring, AnnaMaria Peterffy, Goran Tornling, Sami Z Daoud, Koustubh Ranade, Sally Hollis & Gene Colice
Protocol: Clinical Investigation
-
Strategies to overcome endocrine therapy resistance in hormone receptor-positive advanced breast cancer
Rowan T Chlebowski
Review: Clinical Trail Outcomes: Clinical Investigation
-
Strategies to overcome endocrine therapy resistance in hormone receptor-positive advanced breast cancer
Rowan T Chlebowski
Review: Clinical Trail Outcomes: Clinical Investigation
-
Strategies to overcome endocrine therapy resistance in hormone receptor-positive advanced breast cancer
Rowan T Chlebowski
Review: Clinical Trail Outcomes: Clinical Investigation
-
Strategies to overcome endocrine therapy resistance in hormone receptor-positive advanced breast cancer
Rowan T Chlebowski
Review: Clinical Trail Outcomes: Clinical Investigation
-
Strategies to overcome endocrine therapy resistance in hormone receptor-positive advanced breast cancer
Rowan T Chlebowski
Review: Clinical Trail Outcomes: Clinical Investigation
-
Strategies to overcome endocrine therapy resistance in hormone receptor-positive advanced breast cancer
Rowan T Chlebowski
Review: Clinical Trail Outcomes: Clinical Investigation
-
Strategies to overcome endocrine therapy resistance in hormone receptor-positive advanced breast cancer
Rowan T Chlebowski
Review: Clinical Trail Outcomes: Clinical Investigation
-
Strategies to overcome endocrine therapy resistance in hormone receptor-positive advanced breast cancer
Rowan T Chlebowski
Review: Clinical Trail Outcomes: Clinical Investigation
-
Design of clinical trials for biomarker research in oncology
Sumithra J Mandrekar, Daniel J Sargent
Clinical Trail Outcomes: Clinical Investigation
-
Design of clinical trials for biomarker research in oncology
Sumithra J Mandrekar, Daniel J Sargent
Clinical Trail Outcomes: Clinical Investigation
-
Design of clinical trials for biomarker research in oncology
Sumithra J Mandrekar, Daniel J Sargent
Clinical Trail Outcomes: Clinical Investigation
-
Design of clinical trials for biomarker research in oncology
Sumithra J Mandrekar, Daniel J Sargent
Clinical Trail Outcomes: Clinical Investigation
-
Design of clinical trials for biomarker research in oncology
Sumithra J Mandrekar, Daniel J Sargent
Clinical Trail Outcomes: Clinical Investigation
-
Design of clinical trials for biomarker research in oncology
Sumithra J Mandrekar, Daniel J Sargent
Clinical Trail Outcomes: Clinical Investigation
-
Design of clinical trials for biomarker research in oncology
Sumithra J Mandrekar, Daniel J Sargent
Clinical Trail Outcomes: Clinical Investigation
-
Design of clinical trials for biomarker research in oncology
Sumithra J Mandrekar, Daniel J Sargent
Clinical Trail Outcomes: Clinical Investigation
-
Nilotinib for the treatment of newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia: review of the latest clinical evidence
Massimo Breccia, Giuliana Alimena
Review Article: Clinical Investigation
-
Nilotinib for the treatment of newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia: review of the latest clinical evidence
Massimo Breccia, Giuliana Alimena
Review Article: Clinical Investigation
-
Nilotinib for the treatment of newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia: review of the latest clinical evidence
Massimo Breccia, Giuliana Alimena
Review Article: Clinical Investigation
-
Nilotinib for the treatment of newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia: review of the latest clinical evidence
Massimo Breccia, Giuliana Alimena
Review Article: Clinical Investigation
-
Nilotinib for the treatment of newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia: review of the latest clinical evidence
Massimo Breccia, Giuliana Alimena
Review Article: Clinical Investigation
-
Nilotinib for the treatment of newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia: review of the latest clinical evidence
Massimo Breccia, Giuliana Alimena
Review Article: Clinical Investigation
-
Nilotinib for the treatment of newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia: review of the latest clinical evidence
Massimo Breccia, Giuliana Alimena
Review Article: Clinical Investigation
-
Nilotinib for the treatment of newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia: review of the latest clinical evidence
Massimo Breccia, Giuliana Alimena
Review Article: Clinical Investigation
-
Is there a future for CETP-inhibitor therapy?
Jennifer G Robinson
Editorial: Clinical Investigation
-
Is there a future for CETP-inhibitor therapy?
Jennifer G Robinson
Editorial: Clinical Investigation
-
Is there a future for CETP-inhibitor therapy?
Jennifer G Robinson
Editorial: Clinical Investigation
-
Is there a future for CETP-inhibitor therapy?
Jennifer G Robinson
Editorial: Clinical Investigation
-
Is there a future for CETP-inhibitor therapy?
Jennifer G Robinson
Editorial: Clinical Investigation
-
Is there a future for CETP-inhibitor therapy?
Jennifer G Robinson
Editorial: Clinical Investigation
-
Is there a future for CETP-inhibitor therapy?
Jennifer G Robinson
Editorial: Clinical Investigation
-
Is there a future for CETP-inhibitor therapy?
Jennifer G Robinson
Editorial: Clinical Investigation